Is ELAN or ESPR more undervalued in 2026?

CirclFi compares Elanco Animal Health Incorporat (ELAN) and Esperion Therapeutics, Inc. (ESPR) using 13 institutional-grade valuation models. ELAN has a Quality of Company score of 7.6/10 while ESPR scores 5.2/10.

Which is a better buy — ELAN or ESPR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ELAN and ESPR valuations compare?

ELAN at $23.98 and ESPR at $3.13 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ELAN vs ESPR Valuation Comparison 2026 — Intrinsic Value Analysis

ELAN

Drug Manufacturers - Specialty & Generic

Elanco Animal Health Incorporat

Quality

7.6

out of 10

Value Trap

LOW

Price

$23.98

Last close

Models

12/13

Active

ESPR

Drug Manufacturers - Specialty & Generic

Esperion Therapeutics, Inc.

Quality

5.2

out of 10

Value Trap

LOW

Price

$3.13

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	ELAN Fair Value	ELAN Upside	ESPR Fair Value	ESPR Upside
Bayesian DCF	Intrinsic	$0.37	-98.5%	$1.09	-65.0%
Earnings Power Value	Intrinsic	$2.89	-87.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$26.93	+12.3%	$2.33	-25.7%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ELAN vs ESPR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ELAN vs ESPR — Which Stock Is More Undervalued?

ELAN scores higher with a 7.6/10 quality rating vs ESPR's 5.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Elanco Animal Health Incorporat (ELAN) and Esperion Therapeutics, Inc. (ESPR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ELAN currently trades at $23.98 with a QOC of 7.6/10, while ESPR trades at $3.13 with a QOC of 5.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).